Fenofibrate
Pricing Report NDC 68382-270-16

Latest NADAC: $0.20792 per EA · Effective Sep 22, 2021
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Fenofibrate (NDC 68382-270-16) is $0.20792 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 22, 2021.

As a provided by Zydus Pharmaceuticals Usa Inc, this medication is distributed in a 90 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.20792
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 22, 2021
Data Status
As of Oct 06, 2021
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
68382-270-16
Description
90 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2016, the NADAC wholesale price for (NDC ) has moved within a range of $0.18780 to $0.74610 per EA. Over this 5 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1878 - $0.7461
Market Volatility
297.28% Variance
Latest Trend
5.43%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 22, 2021 $0.20792 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 18, 2021 $0.19722 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 21, 2021 $0.20183 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 23, 2021 $0.19198 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 19, 2021 $0.20114 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 21, 2021 $0.20863 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 17, 2021 $0.24319 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 17, 2021 $0.26273 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 20, 2021 $0.24958 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 23, 2020 $0.19916 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 18, 2020 $0.23793 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 21, 2020 $0.24289 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026